Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24007748

Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2013 Oct
First author
Miguel JS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2013 Oct;14(11):1028-1029. doi: 10.1016/S1470-2045(13)70399-1.
    note
    Source null
    related pmid
    24007745
    relationship
    Comment in

Authors and identifiers

  1. name
    Miguel JS
    type
    Author
  2. name
    Weisel K
    type
    Author
  3. name
    Moreau P
    type
    Author
  4. name
    Lacy M
    type
    Author
  5. name
    Song K
    type
    Author
  6. name
    Delforge M
    type
    Author
  7. name
    Karlin L
    type
    Author
  8. name
    Goldschmidt H
    type
    Author
  9. name
    Banos A
    type
    Author
  10. name
    Oriol A
    type
    Author
  11. name
    Alegre A
    type
    Author
  12. name
    Chen C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Miguel JS
    type
    Author
  2. name
    Weisel K
    type
    Author
  3. name
    Moreau P
    type
    Author
  4. name
    Lacy M
    type
    Author
  5. name
    Song K
    type
    Author
  6. name
    Delforge M
    type
    Author
  7. name
    Karlin L
    type
    Author
  8. name
    Goldschmidt H
    type
    Author
  9. name
    Banos A
    type
    Author
  10. name
    Oriol A
    type
    Author
  11. name
    Alegre A
    type
    Author
  12. name
    Chen C
    type
    Author
bibliography ids
  1. nci-bib-ba815bb9e2826a43cd29f59e
book metadata
content sha256
fc9398f59236055e4d2bbb9d316a6d26a0f6e6b19b931ae7884c8a91507cfd23
document type
citation
dois
  1. 10.1016/S1470-2045(13)70380-2
electronic publication date
display
2013 Sep 3
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:24007748
immutable id
pubmed:24007748@fc9398f59236055e4d2bbb9d316a6d26a0f6e6b19b931ae7884c8a91507cfd23
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
11
name
The Lancet. Oncology
nlm unique id
100957246
pages
1055-1066
volume
14
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2013 Oct;14(11):1028-1029. doi: 10.1016/S1470-2045(13)70399-1.
    note
    Source null
    related pmid
    24007745
    relationship
    Comment in
outcomes validated
false
pmid
24007748
provenance
batch id
0a08f044391426feb8ef
provider
NCBI PubMed ESummary
record sha256
1996d8604cbdcd5572b21050d7bdd11bc5df0b13a61df349917fdf6d8eca70da
response sha256
d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
retrieved at
2026-09-09T23:46:57.614689+00:00
publication date
display
2013 Oct
precision
month
year
2013
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24007748/
title
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial.

Preserved source evidence · Not medical advice